{"entity":{"type":"insider","cik":"0001487100","url":"/insider/0001487100","json_url":"/insider/0001487100.json","name":"Baity Glenn","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":20,"first":"2012-11-29","last":"2018-01-31","span_basis":"filed_date"},"name_variants":[{"name":"Baity Glenn","source":"filing","n_filings":20,"first_seen":"2012-11-29","last_seen":"2018-01-31"}],"transactions":[{"id":6485710,"accession":"0001415889-18-000158","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-18-000158","line_url":"/filing/0001415889-18-000158#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36558.0,"shares_display":"36,558","price_per_share":32.3884,"price_display":"32.39","price_state":"stated","total_value":1184055.1272,"total_display":"1,184,055.13","total_whole":"1,184,055","shares_owned_after":83734.0,"shares_owned_after_display":"83,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-29","filed_date":"2018-01-31","scope":"insider"},{"id":6086558,"accession":"0001415889-18-000014","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-18-000014","line_url":"/filing/0001415889-18-000014#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74321.0,"shares_display":"74,321","price_per_share":30.1414,"price_display":"30.14","price_state":"stated","total_value":2240138.9894,"total_display":"2,240,138.99","total_whole":"2,240,139","shares_owned_after":70113.0,"shares_owned_after_display":"70,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":4849522,"accession":"0001415889-17-001636","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-17-001636","line_url":"/filing/0001415889-17-001636#line-6","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37500.0,"shares_display":"37,500","price_per_share":40.9078,"price_display":"40.91","price_state":"stated","total_value":1534042.5,"total_display":"1,534,042.50","total_whole":"1,534,043","shares_owned_after":69656.0,"shares_owned_after_display":"69,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-05","filed_date":"2017-10-06","scope":"insider"},{"id":5145168,"accession":"0001415889-17-001447","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-17-001447","line_url":"/filing/0001415889-17-001447#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26507.0,"shares_display":"26,507","price_per_share":34.8706,"price_display":"34.87","price_state":"stated","total_value":924314.9942,"total_display":"924,314.99","total_whole":"924,315","shares_owned_after":67656.0,"shares_owned_after_display":"67,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-30","filed_date":"2017-09-01","scope":"insider"},{"id":5265085,"accession":"0001415889-17-001378","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-17-001378","line_url":"/filing/0001415889-17-001378#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14322.0,"shares_display":"14,322","price_per_share":34.8788,"price_display":"34.88","price_state":"stated","total_value":499534.1736,"total_display":"499,534.17","total_whole":"499,534","shares_owned_after":77656.0,"shares_owned_after_display":"77,656","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-09","filed_date":"2017-08-11","scope":"insider"},{"id":4505055,"accession":"0001415889-17-001265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-17-001265","line_url":"/filing/0001415889-17-001265#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38097.0,"shares_display":"38,097","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":1142910.0,"total_display":"1,142,910.00","total_whole":"1,142,910","shares_owned_after":71156.0,"shares_owned_after_display":"71,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider"},{"id":4207056,"accession":"0001415889-17-001046","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-17-001046","line_url":"/filing/0001415889-17-001046#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1903.0,"shares_display":"1,903","price_per_share":30.0004,"price_display":"30.00","price_state":"stated","total_value":57090.7612,"total_display":"57,090.76","total_whole":"57,091","shares_owned_after":81156.0,"shares_owned_after_display":"81,156","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-22","filed_date":"2017-06-26","scope":"insider"},{"id":4849292,"accession":"0001415889-17-000281","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-17-000281","line_url":"/filing/0001415889-17-000281#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26365.0,"shares_display":"26,365","price_per_share":39.6555,"price_display":"39.66","price_state":"stated","total_value":1045517.2575,"total_display":"1,045,517.26","total_whole":"1,045,517","shares_owned_after":67063.0,"shares_owned_after_display":"67,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2017-02-16","scope":"insider"},{"id":4206815,"accession":"0001415889-17-000182","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-17-000182","line_url":"/filing/0001415889-17-000182#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31078.0,"shares_display":"31,078","price_per_share":35.1497,"price_display":"35.15","price_state":"stated","total_value":1092382.3766,"total_display":"1,092,382.38","total_whole":"1,092,382","shares_owned_after":67063.0,"shares_owned_after_display":"67,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-01","filed_date":"2017-02-03","scope":"insider"},{"id":2898236,"accession":"0001415889-16-007636","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-16-007636","line_url":"/filing/0001415889-16-007636#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9800.0,"shares_display":"9,800","price_per_share":30.4565,"price_display":"30.46","price_state":"stated","total_value":298473.7,"total_display":"298,473.70","total_whole":"298,474","shares_owned_after":71563.0,"shares_owned_after_display":"71,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-27","filed_date":"2016-12-29","scope":"insider"},{"id":2898227,"accession":"0001415889-16-007629","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-16-007629","line_url":"/filing/0001415889-16-007629#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0001,"price_display":"30.00","price_state":"stated","total_value":300001.0,"total_display":"300,001.00","total_whole":"300,001","shares_owned_after":71563.0,"shares_owned_after_display":"71,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-20","filed_date":"2016-12-21","scope":"insider"},{"id":2151587,"accession":"0001415889-16-007417","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-16-007417","line_url":"/filing/0001415889-16-007417#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10200.0,"shares_display":"10,200","price_per_share":30.0674,"price_display":"30.07","price_state":"stated","total_value":306687.48,"total_display":"306,687.48","total_whole":"306,687","shares_owned_after":62921.0,"shares_owned_after_display":"62,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-10","filed_date":"2016-11-14","scope":"insider"},{"id":2338729,"accession":"0001415889-16-006486","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001415889-16-006486","line_url":"/filing/0001415889-16-006486#line-7","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11943.0,"shares_display":"11,943","price_per_share":35.0022,"price_display":"35.00","price_state":"stated","total_value":418031.2746,"total_display":"418,031.27","total_whole":"418,031","shares_owned_after":62921.0,"shares_owned_after_display":"62,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-12","filed_date":"2016-07-13","scope":"insider"},{"id":2338712,"accession":"0001415889-16-006486","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-16-006486","line_url":"/filing/0001415889-16-006486#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4057.0,"shares_display":"4,057","price_per_share":35.0016,"price_display":"35.00","price_state":"stated","total_value":142001.4912,"total_display":"142,001.49","total_whole":"142,001","shares_owned_after":62921.0,"shares_owned_after_display":"62,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-11","filed_date":"2016-07-13","scope":"insider"},{"id":3058713,"accession":"0001415889-16-004978","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-16-004978","line_url":"/filing/0001415889-16-004978#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (EVP AND GC)","role_mark":"O","role_mark_label":"Officer (EVP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":20.7971,"price_display":"20.80","price_state":"stated","total_value":145579.7,"total_display":"145,579.70","total_whole":"145,580","shares_owned_after":62921.0,"shares_owned_after_display":"62,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-02","filed_date":"2016-03-04","scope":"insider"},{"id":6944519,"accession":"0001415889-14-000708","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-14-000708","line_url":"/filing/0001415889-14-000708#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (VP AND GC)","role_mark":"O","role_mark_label":"Officer (VP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42000.0,"shares_display":"42,000","price_per_share":30.279,"price_display":"30.28","price_state":"stated","total_value":1271718.0,"total_display":"1,271,718.00","total_whole":"1,271,718","shares_owned_after":47788.0,"shares_owned_after_display":"47,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-26","filed_date":"2014-02-28","scope":"insider"},{"id":4502253,"accession":"0001415889-13-000817","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-13-000817","line_url":"/filing/0001415889-13-000817#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (VP AND GC)","role_mark":"O","role_mark_label":"Officer (VP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":13.1493,"price_display":"13.15","price_state":"stated","total_value":131493.0,"total_display":"131,493.00","total_whole":"131,493","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-22","filed_date":"2013-04-24","scope":"insider"},{"id":4614001,"accession":"0001415889-13-000778","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-13-000778","line_url":"/filing/0001415889-13-000778#line-8","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (VP AND GC)","role_mark":"O","role_mark_label":"Officer (VP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.26,"price_display":"12.26","price_state":"stated","total_value":122600.0,"total_display":"122,600.00","total_whole":"122,600","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-17","filed_date":"2013-04-17","scope":"insider"},{"id":4613993,"accession":"0001415889-13-000778","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-13-000778","line_url":"/filing/0001415889-13-000778#line-6","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (VP AND GC)","role_mark":"O","role_mark_label":"Officer (VP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":12.3,"price_display":"12.30","price_state":"stated","total_value":246000.0,"total_display":"246,000.00","total_whole":"246,000","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-16","filed_date":"2013-04-17","scope":"insider"},{"id":4613982,"accession":"0001415889-13-000778","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-13-000778","line_url":"/filing/0001415889-13-000778#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (VP AND GC)","role_mark":"O","role_mark_label":"Officer (VP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-15","filed_date":"2013-04-17","scope":"insider"},{"id":5115695,"accession":"0001415889-13-000740","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001415889-13-000740","line_url":"/filing/0001415889-13-000740","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (VP AND GC)","role_mark":"O","role_mark_label":"Officer (VP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":12.826666666666666,"price_display":"12.83","price_state":"stated","total_value":384800.0,"total_display":"384,800.00","total_whole":"384,800","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-12","filed_date":"2013-04-12","scope":"insider","n_lines":2},{"id":5115675,"accession":"0001415889-13-000740","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-13-000740","line_url":"/filing/0001415889-13-000740","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (VP AND GC)","role_mark":"O","role_mark_label":"Officer (VP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":12.02,"price_display":"12.02","price_state":"stated","total_value":360600.0,"total_display":"360,600.00","total_whole":"360,600","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-11","filed_date":"2013-04-12","scope":"insider","n_lines":3},{"id":4833026,"accession":"0001415889-13-000633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-13-000633","line_url":"/filing/0001415889-13-000633#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (VP AND GC)","role_mark":"O","role_mark_label":"Officer (VP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13163.0,"shares_display":"13,163","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":105304.0,"total_display":"105,304.00","total_whole":"105,304","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-02","filed_date":"2013-04-03","scope":"insider"},{"id":2355751,"accession":"0001415889-12-001793","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-12-001793","line_url":"/filing/0001415889-12-001793#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (VP AND GC)","role_mark":"O","role_mark_label":"Officer (VP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4396.0,"shares_display":"4,396","price_per_share":5.2526,"price_display":"5.25","price_state":"stated","total_value":23090.4296,"total_display":"23,090.43","total_whole":"23,090","shares_owned_after":43163.0,"shares_owned_after_display":"43,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-28","filed_date":"2012-11-29","scope":"insider"},{"id":2355745,"accession":"0001415889-12-001793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-12-001793","line_url":"/filing/0001415889-12-001793#line-1","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001487100","owner_name":"Baity Glenn","owner_display_name":"Baity Glenn","owner_url":"/insider/0001487100","role":"Officer (VP AND GC)","role_mark":"O","role_mark_label":"Officer (VP AND GC)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP AND GC","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16206.0,"shares_display":"16,206","price_per_share":6.2788,"price_display":"6.28","price_state":"stated","total_value":101754.2328,"total_display":"101,754.23","total_whole":"101,754","shares_owned_after":47559.0,"shares_owned_after_display":"47,559","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-27","filed_date":"2012-11-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":28,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (EVP AND GC)","n_filings":20,"first_seen":"2012-11-29","last_seen":"2018-01-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001487100","retrieved_at":"2026-08-27T16:44:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}